I finally really listened to the most recent webcast (http://web.servicebureau.net/conf/meta?i=1112828043&c=2343&m=was&u=/w_ccbn.xsl&date_... ) from Biomarin and updated the timeline sections on this board. Lots of upcoming presentations and conferences. I still highly recommend that any who has not heard the most recent webcast to listen to it before it is no longer available for replay. It basically lays out the company and where it is head for upcoming future. I will definitely be adding more BMRN to my account at these levels. Great buying opportunity. Cheers!
Recent BMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:53:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:50:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:48:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:34:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 05:42:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:48:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:43:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 11:55:45 PM
- BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M • PR Newswire (US) • 03/12/2026 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 07:23:14 PM
- U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) • PR Newswire (US) • 02/28/2026 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:49:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:39:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:31:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:28:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 06:59:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 05:30:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 03:18:05 PM
- BioMarin to Participate in Four Upcoming Investor Conferences in March • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:08:42 PM
- BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results • PR Newswire (US) • 02/23/2026 09:05:00 PM
- BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET • PR Newswire (US) • 02/17/2026 02:00:00 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:01:49 AM
